Search hospitals > Colorado > Colorado Springs
Memorial Hospital North
Claim this profileColorado Springs, Colorado 80920
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Adenocarcinoma
79 reported clinical trials
26 medical researchers
Summary
Memorial Hospital North is a medical facility located in Colorado Springs, Colorado. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Memorial Hospital North is involved with conducting 79 clinical trials across 207 conditions. There are 26 research doctors associated with this hospital, such as Bradley R. Corr, Jose M. Pacheco, Robert Hoyer, MD, and Breelyn Wilky, M.D..Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage II
Stage IV
Stage I
Top PIs
Bradley R. CorrUniversity of Colorado Hospital1 year of reported clinical research
Studies Ovarian Cancer
Studies Cancer
20 reported clinical trials
33 drugs studied
Jose M. PachecoUniversity of Colorado Hospital4 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
17 reported clinical trials
30 drugs studied
Robert Hoyer, MDUCHealth Memorial Hospital Central4 years of reported clinical research
Studies Cancer
Studies Tumors
18 reported clinical trials
33 drugs studied
Breelyn Wilky, M.D.University of Colorado1 year of reported clinical research
Studies Sarcoma
Studies Soft Tissue Sarcoma
17 reported clinical trials
28 drugs studied
Clinical Trials running at Memorial Hospital North
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Rectal Cancer
Small Cell Lung Cancer
Cancer
Colorectal Cancer
Colon Cancer
Ovarian Tumors
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Memorial Hospital North?
Memorial Hospital North is a medical facility located in Colorado Springs, Colorado. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Memorial Hospital North is involved with conducting 79 clinical trials across 207 conditions. There are 26 research doctors associated with this hospital, such as Bradley R. Corr, Jose M. Pacheco, Robert Hoyer, MD, and Breelyn Wilky, M.D..